{{Rsnum
|rsid=10017238
|Gene=ODZ3
|Chromosome=4
|position=182766636
|Orientation=plus
|GMAF=0.2268
|Gene_s=ODZ3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 21.2 | 78.8
| HCB | 11.7 | 46.7 | 41.6
| JPT | 11.5 | 43.4 | 45.1
| YRI | 0.7 | 15.0 | 84.4
| ASW | 1.8 | 28.1 | 70.2
| CHB | 11.7 | 46.7 | 41.6
| CHD | 10.1 | 35.8 | 54.1
| GIH | 4.0 | 26.7 | 69.3
| LWK | 1.8 | 26.4 | 71.8
| MEX | 5.2 | 48.3 | 46.6
| MKK | 0.0 | 17.3 | 82.7
| TSI | 1.0 | 22.5 | 76.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=7E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}